COVID-19 Fact or Fiction? Week of November 9
November 9, 2020
Fact or Fiction? Reopening schools increased risk of SARS-CoV-2 severe outcomes in adults living with school children.
COVID-19 Fact or Fiction? Week of November 2
November 2, 2020
Fact or Fiction? Myocardial injury is common in patients hospitalized with SARS-CoV-2 infection.
Our partnership with COSA
October 29, 2020
Our partnership with COSA accommodates your eLearning CPD needs. Explore our three most recent CPD programs (listed below) which are developed in collaboration with or endorsed by the Clinical Oncology Society of Australia (COSA) and delivered to you by leading Australian professors and oncology consultants. Note: Fellows of the Royal Australasian College of Physicians (RACP) can easily claim their CPD credits in MyCPD.
COVID-19 Fact or Fiction? Week of October 26
October 27, 2020
Fact or Fiction? Adults with Down syndrome are at 10 times higher risk of dying from COVID-19 when compared to adults without Down syndrome.
COVID-19 Fact or Fiction? Week of October 19
October 19, 2020
Fact or Fiction? Antiviral medications do not improve mortality rates of hospitalized patients with COVID-19.
COVID-19 Fact or Fiction? Week of October 12
October 12, 2020
Fact or Fiction? SARS-CoV-2 and influenza A virus have been shown to have a similar survival on human skin.
COVID-19 Fact or Fiction? Week of October 5
October 5, 2020
Fact or Fiction? Wearing eyeglasses at least 8 hours may reduce the risk of COVID-19.
MDBriefCase Acquires OncologyEducation to Significantly Advance its Oncology Platform
October 1, 2020
MDBriefCase Group Inc. (MDBC), Canada’s leading provider of online continuing medical education and professional development for healthcare providers, is excited to announce the acquisition of OncologyEducation. OncologyEducation is a comprehensive online platform providing evidence-based oncology content, developed and authored by a leading, international faculty of oncology professionals. “We are excited to add OncologyEducation to our family of online educational resources for healthcare professionals,” said Jason Flowerday, CEO of MDBC. “This acquisition aligns with our commitment to investing in critical therapeutic areas to provide our worldwide members with the latest scientific resources for informed healthcare decision-making. Together, MDBriefCase and OncologyEducation serves to provide the pharmaceutical and biotech sectors with improved access and reach to innovative medical education opportunities and programming.” “OncologyEducation was founded on the principle of improving patient care by providing oncology professionals worldwide with the latest oncology information resources,” said Dr. Berry, co-founder of OncologyEducation. “We are a global organization that has grown to have strong credibility among healthcare professionals around the world, and we are confident that MDBriefCase’s track record of global success can further expand the reach and impact of quality oncology education through its innovative offerings.” Since 2001, MDBC has delivered interactive, peer-reviewed, and evidence-based programs […]